Author

Gregory A. Hosler

Propath Services (United States)ORCID 0000-0002-6281-0565Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1

Frequent Co-Authors

Andrew Day· 1 shared Arjun M. BashyamiD· 1 shared Breelyn Wilky· 1 shared Donald Dlass· 1 shared Dong-Min Yu· 1 shared Doreen N. PalsgroveiD· 1 shared Dylan M. MarchioneiD· 1 shared E L Lee· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew Day

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors

Dong-Min Yu, E L Lee, Gabriel J. Starrett, Zili Zhai, Eleanor M. Dowell, Kaitlyn Walsh, Andrew Day, Doreen N. Palsgrove, Justin Bishop, Dylan M. Marchione, Maryam Asgari, Stephen S. Chung, W.L. High, Joyce M. C. Teng, Josh Wissell, , Richard C Wang

This study identifies low-variant allele frequency IDH1/2 mutations in sporadic angiosarcoma and shows they drive tumorigenesis through non-cell-autonomous mechanisms, responding to ivosidenib treatment.

bioRxiv · May 17, 2026 · PreprintCancer Biology

Proteomics and single-cell transcriptomics identify LRP1 as a diagnostic biomarker for atypical fibroxanthoma and pleomorphic dermal sarcoma.

Joshua J. Lingo, Maggie M. Balas, Arjun M. Bashyam, Gregory A. Hosler, Galen T Squiers, Jason C. Klein

The paper identifies LRP1 as a more accurate biomarker for diagnosing atypical fibroxanthoma and pleomorphic dermal sarcoma compared to existing markers.

bioRxiv · Feb 9, 2026 · PreprintCancer Biology